- Home
- RPRX vs BEKE Comparison
RPRX vs BEKE Comparison
Compare RPRX & BEKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | BEKE |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 18.4B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RPRX | BEKE |
|---|---|---|
| Price | $46.19 | $16.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $47.75 | $24.36 |
| AVG Volume (30 Days) | 3.1M | ★ 3.6M |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | 2.01% | ★ 2.11% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $2,378,193,000.00 | N/A |
| Revenue This Year | $38.30 | $5.37 |
| Revenue Next Year | $4.80 | $2.18 |
| P/E Ratio | ★ $26.22 | $41.26 |
| Revenue Growth | ★ 5.06 | N/A |
| 52 Week Low | $29.66 | $15.26 |
| 52 Week High | $47.86 | $25.17 |
Technical Indicators
Market Signals| Indicator | RPRX | BEKE |
|---|---|---|
| Relative Strength Index (RSI) | 58.46 | 42.57 |
| Support Level | $35.32 | $16.12 |
| Resistance Level | $46.14 | $17.73 |
| Average True Range (ATR) | 0.90 | 0.44 |
| MACD | -0.19 | -0.02 |
| Stochastic Oscillator | 37.86 | 16.38 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About BEKE KE Holdings Inc (each representing three)
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.